An organic-inorganic hybrid compound, [NH3(CH2)5NH3]SbCl5, exhibits a switchable second harmonic generation (SHG) effect between SHG-OFF and SHG-ON states and tunable dielectric behaviors between high and low dielectric states, connected with the changes in the dynamics of 1,5-pentanediammonium cations during its centrosymmetric-to-noncentrosymmetric symmetry breaking phase transition at 365.4 K.
C 6 N 2 H 18 ][SbI 5 ] (1), a novel metal halide semiconductor with dielectric relaxation behavior, has been successfully synthesized, in which the cavities between the one-dimensional [SbI 5 ] n 2− polyanions are occupied by 2-methyl-1,5pentanediammonium (2-MPDA) cations. 1 undergoes a reversible solid-state phase transition at T C = 192.7 K and shows a step-like dielectric anomaly. Interestingly, above T C , distinct dielectric dispersion in a wide temperature range is also witnessed. Remarkably, the solid state UV−vis diffuse reflectance spectrum of 1 exhibits a slightly gentler absorption edge at about 650 nm; that is, 1 adopts an indirect band gap with 1.92 electron volts. The combined narrow band gap, strong photoconductivity effect, and excellent dielectric relaxation might shed light on the exploitation of lead-free hybrid metal halide molecular materials with promising application prospects in thermoresponsive relaxation-type dielectric materials and photovoltaic conversion devices.
A layered organic-inorganic hybrid compound, tetra(cyclopentylammonium) decachlorotricadmate(II) (1), in which the two-dimensional [Cd3Cl10](4-)n networks built up from three face-sharing CdCl6 octahedra are separated by cyclopentylammonium cation bilayers, has been discovered as a new phase transition material. It undergoes two successive structural phase transitions, at 197.3 and 321.6 K, which were confirmed by differential scanning calorimetry measurements, variable-temperature structural analyses, and dielectric measurements. The crystal structures of 1 determined at 93, 298, and 343 K are solved in P2₁2₁2₁, Pbca, and Cmca, respectively. A precise analysis of the structural differences between these three structures reveals that the origin of the phase transition at 197.3 K is ascribed to the order-disorder transition of the cyclopentylammonium cations, while the phase transition at 321.6 K originates from the distortion of the two-dimensional [Cd3Cl10](4-)n network.
A new one-dimensional organic−inorganic material, 1,5-pentanediammonium pentabromoantimonate (III) (1), exhibits a centrosymmetric-to-non-centrosymmetric symmetry breaking phase transition at 366.5 K, showing a prominent second harmonic generation (SHG) response and dielectric anomalies. The differential scanning calorimetry results indicate the phase transition is a second-order one. The variable-temperature structural analyses reveal that the space group changes from Pnma at 393 K in the high-temperature phase to P2 1 2 1 2 1 at 293 K in the low-temperature phase, accompanied by the loss of a symmetry plane and inversion center. The crystal structure is composed of one-dimensional zigzag chains of corner-sharing SbBr 6 octahedra and 1,5pentanediammonium cations. The origin of the phase transition can be attributed to both the deformation of the zigzag chains and the order−disorder transition of the 1,5-pentanediammonium cations. The compound is SHG-active below the transition temperature, demonstrating its second-order nonlinear optical properties. It is also SHG-inactive above the transition temperature, which further confirms the symmetry breaking phenomenon. These findings will pave a new way to explore organic−inorganic multifunctional phase transition material.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.